IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.
Clinical trial NCT05975931 · TERMINATED
Trial details
- NCT number
- NCT05975931
- Sponsor
- LivaNova
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-20
- Primary completion
- 2024-01-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.